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the period 1st January, 2007 till 31st December, 2007 and
which developed infection. Determination of nosocomial
infections was performed using standardized CDC criteria.
Results: A total of 1382 patients had developed infection
during hospital admission and were included in the study. Of
them, 668 (48.3%) had nosocomial infection and 714 (51.7%)
had community-acquired infection. Among those who devel-
oped nosocomial infections, 216 (32.3%), 172 (25.7%) and
124 (18.6%) had respiratory tract (RTI), urinary tract (UTI)
and blood stream infections (BSI) respectively. Surgical site
infection (SSI) was reported in 86 cases (12.9%). The overall
nosocomial infection rate along the study period was 4.98
per 100 discharged patients. Gram-positive organisms were
reported in 31.8%. MRSA (Methicillin-resistant S. aureus)
was the commonest (10.2%), followed by coagulase nega-
tive staphylococci (8.5%) and MSSA (Methicillin-susceptible
S. aureus, 7.4%). While Gram-negative organisms were
reported in 66.2%, E. coli was the commonest (22.3%),
followed by Pseudomonas aeruginosa (17.6%) and Kleb-
siella pneumoniae (9.9%). Acinetobacter spp. and MRSA
were highly sensitive to Imipenem (88.6%) and Vancomycin
(98.5%) respectively. E. coli were highly sensitive to most of
the antimicrobial agents except ampicillin (26.6%).
Conclusions: Pneumonia, urinary tract infections, and
blood stream infections made up the great majority of noso-
comial infections. There is a need for further risk assessment
associated with main types of infection.
doi:10.1016/j.ijid.2008.05.980
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Background: Bulkholderia cepacia, formerly Pseu-
domonas cepacia is a gram negative rod with a long
association with contaminated disinfectants and medical
devices; and has been responsible for nosocomial infections
as well as pseudobacteremias. This paper documents
isolation of Bulkholderia cepacia from in house prepared
disinfectants; and from the blood and urines of patients
seen at the emergency room (ER) of a tertiary hospital in
Trinidad and Tobago.
Materials and Methods: Eighteen isolates of B. cepacia
were recovered from urine and blood specimens of patients
seen at the ER of the hospital. Medical records of these
patients seen in the ER and on the wards were reviewed.
Blood and urine cultures were performed and examined
according to standard procedures recommended by the Clin-
ical Laboratory Standards Institute (CLSI) using automated
system for isolation and identiﬁcation of micro-organisms.
Samples of Povidone-iodine and Savlon were analyzed by the
same techniques. The biochemical proﬁle and antibiogram
of the B. cepacia isolates from the ER and the disinfectants
were compared with those of B. cepacia strains isolated in
the past from the ICU and wards.
Results: The eighteen B. cepacia isolates from patients
seen at the ER and the isolates from the disinfectants had
a biochemical proﬁle that was compatible with B. cepacia
Group 1. The antibiogram of the isolates from the ER were
all identical but distinctly different from the antibiograms of
B. cepacia strains from the ICU and wards. Patients from ER
from whom these B. cepacia isolates were recovered had no
history and no clinical features suggestive of infection with
this organism. All the patients had a negative repeat blood
cultures and had clinical course that was incompatible with
B. cepacia bacteremia or septicaemia.
Conclusions: The identical biochemical proﬁle and antibi-
ogram of the isolates from the ER point to the same organism
and therefore a common source of contamination. This
report therefore highlights the danger of using bulk cen-
trally prepared disinfectants that are frequently opened for
use over a period of days. Contamination during this process
leads to costly investigations, unnecessary antibiotics and
has the potential for causing nosocomial infection. Proper
preparation and management of disinfectants need to be
emphasized.
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Objectives: To describe the demographics, microbiology
and antibiotic use in Ventilator Associated Pneumonia (VAP)
in a 20 bedded mixed medical and surgical intensive care
unit.
Methods: Prospective surveillance among all patients
who developed VAP while receiving mechanical ventilation
for at least 48 hours, from April 2006 through January 2008.
VAP Inclusion criteria were based on National Nosocomial
Surveillance (NNIS) system deﬁnitions
Results: There were 2162 admissions during the study
period and a total of 2490 ventilator days. Twenty-ﬁve
patients met the criteria for VAP. The majority (23/25,
92%) were males. Mean age was 41 years. The VAP rate
was 10.36/1,000 ventilator-days with a ventilator utilization
ratio of 0.36. Most of patients (17/25, 68%) were surgical of
which severe head trauma (13/17, 76%). was the common-
est underlying diagnosis. Early VAP (<96 hours of mechanical
ventilation) occurred in 14/25 (56%) patients. Head trauma
cases comprised more than half of early VAP (8/14, 57.1%).
There was no growth in 6/25(40%). Klebsiella pneumo-
niae was the commonest organism (4/19, 21%), followed
by Staphylococcus aureus (3/19, 16%) and Pseudomonas
aeruginosa (3/19, 16%). 20/25(80%) patients were receiv-
ing antibiotics at the time of diagnosis. Empiric treatment
of choice was piperacillin-tazobactam alone or in combina-
tion with a quinolone (14/25, 56%), followed by meropenem
(8/25, 32%). In 11/25 cases antibiotic was changed after
culture results. In unit mortality rate for VAP patients was
12%.
